Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
J Nutr Biochem ; 124: 109508, 2024 02.
Article in English | MEDLINE | ID: mdl-37898392

ABSTRACT

With the aim of offsetting immune dysfunction preceded by sarcopenia, the feasibility and efficiency of nutritional leucine supplementation were evaluated using a murine denervation-induced sarcopenia model. Sciatic nerve axotomy caused significant loss of skeletal muscle of the hind limbs and accelerated mitochondrial stress along with suppressed ATP production in spleen-derived T cells. Dietary leucine intake not only ameliorated muscle mass anabolism in a sarcopenic state, but also restored mitochondrial respiratory function, as indicated by elevated levels of basal respiration, maximal respiration, spare respiratory capacity, and ATP production, in T cells, which in turn led to downregulated expression of mTOR and downstream signals, as indicated by the findings of comprehensive transcriptome analysis. Consequentially, this finally resulted in amelioration of the sarcopenia-induced relative Th1/Th17-dominant proinflammatory microenvironment. These results highlight the importance of leucine-promoted metabolic cues in directing T cell fate in a sarcopenic microenvironment. The present study provides insights that particularly help rationalize the design and optimization of leucine supplementation for chronic sarcopenic patients with autoimmune diseases.


Subject(s)
Sarcopenia , Humans , Mice , Animals , Sarcopenia/metabolism , Leucine/pharmacology , Leucine/metabolism , Muscle, Skeletal/metabolism , Dietary Supplements , Respiration , Denervation , Adenosine Triphosphate/metabolism
2.
Life Sci ; 334: 122214, 2023 Dec 01.
Article in English | MEDLINE | ID: mdl-37907153

ABSTRACT

AIMS: The activity and interactions of cellular subpopulations in the adipose tissue microenvironment are critical for the coordination of local and systemic adaptation during pregnancy. With a particular interest in parametrial adipose tissue (PmAT), single-cell RNA-sequencing (scRNA-seq) was utilized to unveil the gestative cellular composition and functional shift. MATERIALS AND METHODS: To identify cell-type-enriched transcriptome profiles, a total of 18,074 cells in adipose tissue were studied. The cell populations were cataloged, and signaling crosstalk between adipocytes and other composition factions via soluble and membrane-bound factors were evaluated. KEY FINDINGS: A marked decline of pregnancy adipocytes and relative elevation of non-adipocyte fractions were observed. A subpopulation of adipocytes, Adipo_5, with unique properties in the response to estrogen and the embryonic processes involved in pregnancy, was defined. Interactome analysis revealed the potential contribution of PmAT to the establishment of maternal-fetal immune tolerance. During gestation, adipocytes shut down outgoing signaling, resulting in deterioration of the resistin-related incoming signaling network in B cells, which would therefore benefit tissue-specific maternal-fetal tolerance. Furthermore, a subpopulation of adipocytes, Aipo_2, was also considered to take part in a paradigm shift in the process of pregnancy-induced chemical stiffness-triggered vesicular remodeling via the THBS signaling pathway network. SIGNIFICANCE: These data-derived findings will encourage investigation into the role of pregnant PmTA in pregnancy-related immunological, hypertensive and metabolic disorders, with the ultimate goal of establishing preventive strategies to mitigate these pregnancy-related health challenges. This translational aspect of our work holds significant promise for improving maternal and fetal well-being.


Subject(s)
Adipose Tissue , Transcriptome , Pregnancy , Female , Mice , Animals , Adipose Tissue/metabolism , Adipocytes/metabolism , Gene Expression Profiling , Cell Communication
3.
Front Oncol ; 13: 1082441, 2023.
Article in English | MEDLINE | ID: mdl-36969081

ABSTRACT

Introduction: The incidence of endometrial cancer (EC) has been increasing worldwide. However, because there are limited chemotherapeutic options for the treatment of EC, the prognosis of advanced-stage EC is poor. Methods: Gene expression profile datasets for EC cases registered in The Cancer Genome Atlas (TCGA) was reanalyzed. Highly expressed genes in advanced-stage EC (110 cases) compared with early-stage EC (255 cases) were extracted and Gene Ontology (GO) enrichment analysis was performed. Among the enriched genes, Kaplan-Meier (KM) plotter analysis was performed. Candidate genes expression was analyzed in HEC50B cells and Ishikawa cells by RT-qPCR. In HEC50B cells, LIM homeobox1 (LIM1) was knocked down (KD) and cell proliferation, migration, and invasion ability of the cells were evaluated. Xenografts were generated using LIM1-KD cells and tumor growth was evaluated. Ingenuity Pathway Analysis (IPA) of RNA-seq data using LIM-KD cells was performed. Expression of phospho-CREB and CREB-related proteins were evaluated in LIM1-KD cells by western blotting and in xenograft tissue by immunofluorescent staining. Two different CREB inhibitors were treated in HEC50B and cell proliferation was evaluated by MTT assay. Results: Reanalysis of TCGA followed by GO enrichment analysis revealed that homeobox genes were highly expressed in advanced-stage EC. Among the identified genes, KM plotter analysis showed that high LIM1 expression was associated with a significantly poorer prognosis in EC. Additionally, LIM1 expression was significantly higher in high-grade EC cell lines, HEC50B cells than Ishikawa cells. Knockdown of LIM1 showed reduced cell proliferation, migration and invasion in HEC50B cells. Xenograft experiments revealed that tumor growth was significantly suppressed in LIM1-KD cells. IPA of RNA-seq data using LIM-KD cells predicted that the mRNA expression of CREB signaling-related genes was suppressed. Indeed, phosphorylation of CREB was decreased in LIM1-KD cells and LIM1-KD cells derived tumors. HEC50B cells treated by CREB inhibitors showed suppression of cell proliferation. Conclusion and discussion: Collectively, these results suggested that high LIM1 expression contributed to tumor growth via CREB signaling in EC. Inhibition of LIM1 or its downstream molecules would be new therapeutic strategies for EC.

4.
Geriatr Gerontol Int ; 23(4): 263-269, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36855031

ABSTRACT

Frailty attracts research as it represents a significant target for intervention to extend the healthy life span. An unanswered question in this field is the time point during the life-course at which an individual becomes predisposed to frailty. Here, we propose that frailty has a fetal origin and should be regarded as part of the spectrum of the developmental origins of health and disease. The developmental origins of health and disease theory originated from findings linking the fetal environment to lifestyle-related disorders such as hypertension and diabetes. Coincidentally, a recent trend in frailty research also centers on vascular dysfunction and metabolic alterations as the causality of lifestyle-related disorders such as sarcopenia and dementia. Here, we explore the relationship between fetal programming, frailty-related disorders (sarcopenia and dementia), and other age-related diseases mainly based on reports on intrauterine growth restriction. We propose a "total" life-course approach to combat frailty. With this viewpoint, not only physicians and gerontologists but also obstetricians and pediatricians should team up to overcome age-related diseases in the elderly. Geriatr Gerontol Int 2023; 23: 263-269.


Subject(s)
Dementia , Diabetes Mellitus , Frailty , Sarcopenia , Humans , Aged , Life Style , Frail Elderly
5.
Gan To Kagaku Ryoho ; 50(1): 59-64, 2023 Jan.
Article in Japanese | MEDLINE | ID: mdl-36759989

ABSTRACT

A variety of immune-related adverse events(irAEs)occur during the use of immune checkpoint inhibitors, and delayed detection may make it difficult to continue treatment. To detect irAEs as early as possible, we have been administering an irAEs self-reported interview system(ISRIS)to all outpatients using a tablet device. We conducted a retrospective study of outpatients who received pembrolizumab, nivolumab, atezolizumab, ipilimumab, and durvalumab and utilized the ISRIS from June 2019 to May 2020. The survey items were the primary disease, initial symptoms of irAEs, and detected irAEs. The total number of patients was 140, and the total number of interviews was 1,095. Overall, 42 irAEs occurred. The ISRIS is useful for detecting subjective skin disorders. However, its detection rate of myocarditis and thyroid, hepatic, and renal dysfunction was low, and there is room for improvement. We are currently developing an ISRIS application that maintains sensitivity and increases specificity to allow for early detection of irAEs at home.


Subject(s)
Nivolumab , Humans , Self Report , Retrospective Studies , Nivolumab/adverse effects , Ipilimumab
6.
Biomolecules ; 11(6)2021 05 31.
Article in English | MEDLINE | ID: mdl-34072941

ABSTRACT

Preeclampsia (PE) is a serious disease that can be fatal for the mother and fetus. The two-stage theory has been proposed as its cause, with the first stage comprising poor placentation associated with the failure of fertilized egg implantation. Successful implantation and placentation require maternal immunotolerance of the fertilized egg as a semi-allograft and appropriate extravillous trophoblast (EVT) invasion of the decidua and myometrium. The disturbance of EVT invasion during implantation in PE results in impaired spiral artery remodeling. PE is thought to be caused by hypoxia during remodeling failure-derived poor placentation, which results in chronic inflammation. High-mobility group protein A (HMGA) is involved in the growth and invasion of cancer cells and likely in the growth and invasion of trophoblasts. Its mechanism of action is associated with immunotolerance. Thus, HMGA is thought to play a pivotal role in successful pregnancy, and its dysfunction may be related to the pathogenesis of PE. The evaluation of HMGA function and its changes in PE might confirm that it is a reliable biomarker of PE and provide prospects for PE treatment through the induction of EVT proliferation and invasion during the implantation.


Subject(s)
Cell Proliferation , Decidua/metabolism , HMGA1a Protein/metabolism , Pre-Eclampsia/metabolism , Trophoblasts/metabolism , Animals , Decidua/pathology , Female , Humans , Pre-Eclampsia/pathology , Pregnancy , Trophoblasts/pathology
7.
J Cutan Pathol ; 48(3): 451-454, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33300158

ABSTRACT

Acantholytic dyskeratotic acanthoma is a rare variant of epidermal acanthoma. It has a flat, plaque-like structure and is characterized microscopically by acantholysis and dyskeratosis. Eccrine syringofibroadenomatous hyperplasia is benign and likely reactive. It has recently been considered as a hyperplastic process affecting the eccrine ducts rather than the neoplasm because of its pathological heterogeneity and wide clinical associations. In this article, we present the case of 97-year-old Japanese women with a 10-mm wide, painful acantholytic dyskeratotic acanthoma accompanied by syringofibroadenomatous hyperplasia in the right femoral region. Although syringofibroadenomatous hyperplasia is known to occur as a reactive process with various dermatoses and cutaneous tumors, to date, there have been no reports of cases of acantholytic dyskeratotic acanthoma accompanying syringofibroadenomatous hyperplasia. Moreover, this case also includes the unusual finding of an increase in the mature sebocytes in the area of the syringofibroadenomatous hyperplasia.


Subject(s)
Acantholysis/pathology , Acanthoma/diagnosis , Epidermis/pathology , Poroma/diagnosis , Skin Neoplasms/pathology , Sweat Gland Neoplasms/pathology , Acantholysis/diagnosis , Acanthoma/surgery , Acanthoma/ultrastructure , Aged, 80 and over , Asian People/ethnology , Cell Proliferation , Diagnosis, Differential , Female , Humans , Hyperplasia/diagnosis , Hyperplasia/pathology , Middle Aged , Pain/diagnosis , Pain/etiology , Poroma/pathology , Skin/pathology
8.
J Plast Reconstr Aesthet Surg ; 74(1): 108-115, 2021 01.
Article in English | MEDLINE | ID: mdl-32586757

ABSTRACT

BACKGROUND: Although the free jejunal graft is commonly used for reconstruction after resection of a tumor of the pharynx or cervical esophagus, adequate monitoring for detecting graft failure is not available. We employed near-infrared spectroscopy to measure regional oxygen saturation (rSO2) in the graft. METHODS: In 25 consecutive cases who underwent reconstructive surgery using a free jejunal graft, the feasibility of postoperative rSO2 monitoring was examined along with the changes in rSO2 values following vascular clamping or reperfusion. RESULTS: No operative mortality occurred, and except for one case of subcutaneous hematoma that necessitated evacuation surgery, no complications related to surgery or graft failure occurred. Postoperative rSO2 monitoring was feasible for >50 hours in most cases. It mostly remained >55% with a stable hemoglobin index (HbI) which reflects tissue hemoglobin density. A marked increase in the HbI was noted in a patient with hematoma. Intraoperatively, the rSO2 of intact jejunal tissue was >60% in every case but dropped within a few minutes after arterial clamping because of decreased oxygenated hemoglobin concentration. With venous clamping, the HbI was elevated while the rSO2 remained unchanged or was slightly decreased. Upon graft reperfusion, the rSO2 rapidly recovered in all 18 cases because of the recovery of oxygenated hemoglobin concentrations. CONCLUSIONS: The near-infrared spectroscopic assessment sensitively and accurately reflected the condition of the jejunal graft. It appears to be a promising postoperative method for monitoring graft perfusion. An rSO2 value of 55% appears to be an adequate criterion for ischemia.


Subject(s)
Autografts/diagnostic imaging , Free Tissue Flaps/physiology , Ischemia/diagnostic imaging , Jejunum/transplantation , Spectroscopy, Near-Infrared , Adult , Aged , Aged, 80 and over , Autografts/blood supply , Autografts/metabolism , Constriction , Esophagoplasty , Esophagus/surgery , Female , Graft Survival , Hemoglobins/metabolism , Humans , Ischemia/metabolism , Jejunum/metabolism , Male , Middle Aged , Monitoring, Physiologic/methods , Oxygen/metabolism , Postoperative Period , Reperfusion
9.
Surg Case Rep ; 4(1): 83, 2018 Jul 31.
Article in English | MEDLINE | ID: mdl-30066205

ABSTRACT

BACKGROUND: The demand for breast reconstruction after mastectomy is rising. The use of deep inferior epigastric perforator (DIEP) flap in autologous reconstruction is a popular approach. There were some reports about abdominal complications after breast reconstruction. However, there was no report about spontaneous rupture of abdominal wall. CASE PRESENTATION: A 46-year-old female patient was diagnosed with left breast cancer. Left mastectomy with sentinel lymph node biopsy was performed, and the breast was reconstructed using DIEP flap simultaneously. She suffered heavy abdominal pain and vomiting at postoperative day 4. Computed tomography showed bowel herniation into the subcutaneous tissue caused by left abdominal wall rupture. The abdominal wall was sutured and repaired using mesh by emergency surgery. CONCLUSIONS: To the best of our knowledge, this is the first case about spontaneous rupture of abdominal wall after breast reconstruction using DIEP flap to be reported in the English literature. DIEP flap on breast reconstructive surgery may cause spontaneous rupture of abdominal wall.

10.
J Cancer ; 8(8): 1371-1377, 2017.
Article in English | MEDLINE | ID: mdl-28638451

ABSTRACT

Purpose The therapeutic benefit of a three-drug combination of antiemetics has not been established in moderately emetogenic chemotherapy (MEC). The aim of this study was to compare the antiemetic effectiveness and cost-saving of palonosetron plus dexamethasone (control group) with aprepitant, granisetron, and dexamethasone (study group) in cancer patients who received MEC. Methods We switched the standard antiemetic treatment from the control group to the study group in gastrointestinal cancer patients who received MEC after October 2015. The antiemetics in both groups were modified using salvage antiemetic therapy at the clinicians' discretion, according to the severity of chemotherapy-induced nausea and vomiting. We retrospectively reviewed the electronic medical records from patients, before and after switching groups, from between April 2014 and March 2016. Results We evaluated 443 treatment courses in 83 patients. The proportion of courses that included salvage antiemetic therapy in the control group and the study group was 34.8 % (116/333) and 8.2 % (9/110), respectively, and was statistically significant (p < 0.001). The mean integrated costs of antiemetics per course in the control group and the study group were 193 ± 55 USD and 143 ± 38 USD, respectively. Multivariate logistic regression analysis revealed that the study group was significantly associated with a reduced risk of requiring salvage antiemetic therapy (p = 0.038). Conclusions These results suggest that the antiemetic effectiveness and cost-saving of a three-drug combination of aprepitant, generic granisetron, and dexamethasone was superior to a two-drug combination of palonosetron plus dexamethasone in gastrointestinal cancer patients who received MEC.

11.
Biochim Biophys Acta Mol Cell Biol Lipids ; 1862(6): 615-622, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28336329

ABSTRACT

We previously demonstrated that the aromatic moiety of Tyr143 within the intracellular loop 2 (ICL2) region of the prostaglandin EP2 receptor plays a crucial role in Gs coupling. Here we investigated whether the ICL2 of the EP2 receptor directly binds to Gαs and whether an aromatic moiety affects this interaction. In Chinese hamster ovary cells, mutations of Tyr143 reduced the ability of the EP2 receptor to interact with G proteins as demonstrated by GTPγS sensitivity, as well as the ability of agonist-induced cAMP formation, with the rank order of Phe>Tyr (wild-type)=Trp>Leu>Ala (=0). We found that the wild-type ICL2 peptide (i2Y) and its mutant with Phe at Tyr143 (i2F) inhibited receptor-G protein complex formation of wild-type EP2 in membranes, whereas the Ala-substituted mutant (i2A) did not. Specific interactions between these peptides and the Gαs protein were detected by surface plasmon resonance, but Gαs showed different association rates, with a rank order of i2F>i2Y≫i2A, with similar dissociation rates. Moreover, i2F and i2Y, but not i2A activated membrane adenylyl cyclase. These results indicate that the ICL2 region of the EP2 receptor is its potential interaction site with Gαs, and that the aromatic side chain moiety at position 143 is a determinant for the accessibility of the ICL2 to the Gαs protein.


Subject(s)
Chromogranins/metabolism , GTP-Binding Protein alpha Subunits, Gs/metabolism , Receptors, Prostaglandin E, EP2 Subtype/metabolism , Amino Acid Substitution , Animals , Chromogranins/chemistry , Chromogranins/genetics , Cricetinae , GTP-Binding Protein alpha Subunits, Gs/chemistry , GTP-Binding Protein alpha Subunits, Gs/genetics , Humans , Mutation, Missense , Protein Domains , Protein Structure, Secondary , Receptors, Prostaglandin E, EP2 Subtype/chemistry , Receptors, Prostaglandin E, EP2 Subtype/genetics
12.
PLoS One ; 12(2): e0171066, 2017.
Article in English | MEDLINE | ID: mdl-28158216

ABSTRACT

PURPOSE: As the major toxicity induced by pemetrexed plus carboplatin is severe hematologic toxicities, the aim of this study was to determine the risk factors for severe hematologic toxicities in lung cancer patients. METHODS: We retrospectively investigated data from lung cancer patients who had received pemetrexed plus carboplatin, with or without bevacizumab. This observational study was carried out at Ehime University Hospital using electronic medical records dating from July 2009 to March 2015. Severe hematologic toxicities were defined as grade 3 or 4, according to the Common Terminology Criteria for Adverse Events, version 4.0. RESULTS: Forty-two patients were included in the study. The incidence of grade 3 or 4 hematologic toxicities during the first cycle of chemotherapy and during all cycles was 19.0% and 16.1%, respectively. Multivariate time-depend generalized estimating equations logistic regression analysis revealed that regular use of non-steroidal anti-inflammatory drugs (NSAIDs) was significantly associated with an increased risk of severe hematologic toxicities during all cycles (adjusted odds ratio (OR): 8.32, 95% confidence interval (CI): 1.27-54.38; p = 0.03), whereas creatinine clearance of <45 mL/min was not significantly associated with an increased risk of severe hematologic toxicities during all cycles (adjusted OR: 0.91, 95% CI: 0.25-3.34; p = 0.88). CONCLUSIONS: The results suggest that severe hematologic toxicities in patients receiving carboplatin-based pemetrexed may be significantly induced by the inhibition of renal tubular pemetrexed secretion through drug-drug interactions between NSAIDs and pemetrexed rather than through glomerular filtration of pemetrexed, even with moderate to sufficient renal function.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Carboplatin/therapeutic use , Hematologic Diseases/chemically induced , Lung Neoplasms/drug therapy , Pemetrexed/therapeutic use , Adult , Aged , Aged, 80 and over , Anemia/blood , Anemia/chemically induced , Anemia/pathology , Female , Hematologic Diseases/blood , Hematologic Diseases/pathology , Humans , Leukopenia/blood , Leukopenia/chemically induced , Leukopenia/pathology , Lung Neoplasms/blood , Lung Neoplasms/pathology , Male , Middle Aged , Multivariate Analysis , Neutropenia/blood , Neutropenia/chemically induced , Neutropenia/pathology , Retrospective Studies , Thrombocytopenia/blood , Thrombocytopenia/chemically induced , Thrombocytopenia/pathology , Treatment Outcome
13.
J Pharm Policy Pract ; 9: 35, 2016.
Article in English | MEDLINE | ID: mdl-27795831

ABSTRACT

BACKGROUND: High oral bioavailability of antimicrobial agents can result in the replacement of intravenous (IV) therapy with oral therapy when a patient meets defined clinical criteria. However, few studies have evaluated the effects of switching antibiotic administration route in Japan, especially for linezolid. This study evaluated an IV-to-oral antibiotic switching program for linezolid treatment at a university hospital in Japan. METHODS: In a retrospective cohort study of 73 patients, we assessed the efficacy and safety of IV-to-oral linezolid therapy (n = 21 patients) compared with IV therapy alone (n = 52 patients). RESULTS: Duration of linezolid treatment, changes in C-reactive protein or platelet count from baseline, re-administration of anti-methicillin-resistant Staphylococcus aureus agent within 90 days of discharge, and mortality within 28 days of discharge were not significantly different between the two groups. CONCLUSIONS: An IV-to-oral switching program could reduce the duration of IV linezolid therapy without worsening clinical outcomes in Japanese patients receiving linezolid therapy.

14.
Surg Today ; 46(3): 326-34, 2016 Mar.
Article in English | MEDLINE | ID: mdl-25940758

ABSTRACT

PURPOSE: In most general thoracic operations performed via standard posterolateral thoracotomy, such as for descending aortic aneurysms and lung cancer, the latissimus dorsi (LD) muscle is divided. However, division of the LD can hamper reconstructive surgery because the initial operation creates unstable blood flow to the divided LD. We conducted this study to assess blood flow in a divided distal LD muscle flap using intraoperative indocyanine green-fluorescence angiography (ICG-FA) with the Hyper Eye Medical System(®) (Mizuho Medical Co., Ltd., Tokyo, Japan). METHODS: The subjects were 11 patients who underwent posterolateral thoracotomy with reconstructive surgery using a divided distal LD and other peripheral muscle flaps. Intraoperative ICG-FA was conducted to assess blood flow to the LD. RESULTS: Intraoperative ICG-FA revealed that at least two intercostal perforators from the sixth to the tenth intercostal spaces were preserved as feeding vessels to the divided distal LD. There were no major complications associated with inadequate blood flow to the muscle flaps. CONCLUSION: Intraoperative ICG-FA proved extremely useful for assessing altered blood flow of the divided LD and for selecting preserved intercostal perforators.


Subject(s)
Aorta, Thoracic/surgery , Aortic Aneurysm/surgery , Lung Neoplasms/surgery , Plastic Surgery Procedures/methods , Superficial Back Muscles/blood supply , Surgical Flaps/physiology , Thoracotomy/methods , Aged , Aged, 80 and over , Female , Fluorescein Angiography , Humans , Indocyanine Green , Intraoperative Period , Male , Middle Aged , Pneumonectomy/methods , Regional Blood Flow , Treatment Outcome
15.
Metab Brain Dis ; 30(3): 813-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25575695

ABSTRACT

It remains unclear whether prolonged febrile seizures (pFS) in childhood facilitate mesial temporal lobe epilepsy (MTLE) in adulthood. Interleukin (IL)-1ß is associated with seizures in children and immature animal models. Here, we use a rat model of pFS to study the effects of IL-1ß on adult epileptogenesis, hippocampal damage, and cognition. We produced prolonged hyperthermia-induced seizures on postnatal days (P) 10-11 and administered IL-1ß or saline intranasally immediately after the seizures. Motor and cognitive functions were assessed at P85 using rotarod and passive avoidance tests. Electroencephalogram recordings were conducted at P90 and P120. Hippocampal CA1 and CA3 neurons and gliosis were quantified at the end of the experiment. Spontaneous seizure incidence was significantly greater in rats that had received IL-1ß than in those that had received saline or those without hyperthermia-induced seizures (p < 0.05). Seizure frequency did not differ significantly between the three groups and no motor deficits were observed. Passive avoidance learning was impaired in rats that received IL-1ß compared with controls (p < 0.05), but was not different from that in rats that received saline. Hippocampal cell numbers and gliosis did not differ between the three groups. These results indicate that neuronal loss and gliosis are not prerequisites for the epileptogenic process that follows pFS. Our results suggest that infantile pFS combined with IL-1ß overproduction can enhance adulthood epileptogenesis, and might contribute to the development of MTLE.


Subject(s)
Epilepsy, Temporal Lobe/chemically induced , Epilepsy, Temporal Lobe/metabolism , Interleukin-1beta/administration & dosage , Interleukin-1beta/toxicity , Seizures, Febrile/metabolism , Age Factors , Animals , Animals, Newborn , Epilepsy, Temporal Lobe/etiology , Female , Humans , Male , Rats , Rats, Inbred Lew , Seizures, Febrile/complications
17.
Nucleic Acids Res ; 38(10): 3489-501, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20156995

ABSTRACT

Many well-characterized examples of antisense RNAs from prokaryotic systems involve hybridization of the looped regions of stem-loop RNAs, presumably due to the high thermodynamic stability of the resulting loop-loop and loop-linear interactions. In this study, the identification of RNA stem-loops that inhibit U1A protein binding to the hpII RNA through RNA-RNA interactions was attempted using a bacterial reporter system based on phage lambda N-mediated antitermination. As a result, loop sequences possessing 7-8 base complementarity to the 5' region of the boxA element important for functional antitermination complex formation, but not the U1 hpII loop, were identified. In vitro and in vivo mutational analysis strongly suggested that the selected loop sequences were binding to the boxA region, and that the structure of the antisense stem-loop was important for optimal inhibitory activity. Next, in an attempt to demonstrate the ability to inhibit the interaction between the U1A protein and the hpII RNA, the rational design of an RNA stem-loop that inhibits U1A-binding to a modified hpII was carried out. Moderate inhibitory activity was observed, showing that it is possible to design and select antisense RNA stem-loops that disrupt various types of RNA-protein interactions.


Subject(s)
RNA, Antisense/chemistry , RNA, Small Nuclear/chemistry , Ribonucleoprotein, U1 Small Nuclear/chemistry , Bacteria/genetics , Genes, Reporter , Mutation , Nucleic Acid Conformation , RNA, Small Nuclear/metabolism , Regulatory Sequences, Ribonucleic Acid , Ribonucleoprotein, U1 Small Nuclear/metabolism , Viral Regulatory and Accessory Proteins/metabolism
18.
Biochem Biophys Res Commun ; 389(4): 678-82, 2009 Nov 27.
Article in English | MEDLINE | ID: mdl-19769944

ABSTRACT

We previously demonstrated that prostaglandin EP3 receptor augments EP2-elicited cAMP formation in COS-7 cells in a G(i/o)-insensitive manner. The purpose of our current study was to identify the signaling pathways involved in EP3-induced augmentation of receptor-stimulated cAMP formation. The enhancing effect of EP3 receptor was irrespective of the C-terminal structure of the EP3 isoform. This EP3 action was abolished by treatment with inhibitors for phospholipase C and intracellular Ca(2+)-related signaling molecules such as U73122, staurosporine, 2-APB and SK&F 96365. Indeed, an EP3 agonist stimulated IP(3) formation and intracellular Ca(2+) mobilization, which was blocked by U73122, but not by pertussis toxin. The enhancing effect by EP3 on cAMP formation was mimicked by both a Ca(2+) ionophore and the activation of a typical G(q)-coupled receptor. Moreover, EP3 was exclusively localized to the raft fraction in COS-7 cells and EP3-elicited augmentation of cAMP formation was abolished by cholesterol depletion and introduction of a dominant negative caveolin-1 mutant. These results suggest that EP3 elicits adenylyl cyclase superactivation via G(q)/phospholipase C activation and intracellular Ca(2+) mobilization in a lipid raft microdomain-dependent manner.


Subject(s)
Adenylyl Cyclases/biosynthesis , Calcium/metabolism , GTP-Binding Protein alpha Subunits, Gq-G11/metabolism , Membrane Microdomains/metabolism , Receptors, Prostaglandin E/metabolism , Type C Phospholipases/metabolism , Animals , Boron Compounds/pharmacology , COS Cells , Caveolin 1/metabolism , Chlorocebus aethiops , Enzyme Activation , Estrenes/pharmacology , Humans , Imidazoles/pharmacology , Ionophores/pharmacology , Pyrrolidinones/pharmacology , Receptors, Prostaglandin E/antagonists & inhibitors , Receptors, Prostaglandin E, EP2 Subtype , Staurosporine/pharmacology , Type C Phospholipases/antagonists & inhibitors
19.
ACS Chem Biol ; 3(6): 341-5, 2008 Jun 20.
Article in English | MEDLINE | ID: mdl-18533657

ABSTRACT

The specific labeling of proteins in living cells using a genetically encodable tag and a small synthetic probe targeting the tag has been craved as an alternative to widely used larger fluorescent proteins. We describe a rapid method with a small tag (21 amino acids) for the fluorescence labeling of cell-surface receptors using a high affinity coiled-coil formation without metals or enzymes. The peptide probes K3 (KIAALKE)3 and K4 (KIAALKE)4 labeled with a fluorophore specifically stained the surface-exposed tag sequence E3 (EIAALEK)3 attached to the N-terminus of the mouse-derived prostaglandin EP3 receptor in living cells (Kd = 64 and 6 nM for K3 and K4, respectively). The labeling was quick (<1 min), nontoxic, and available even in culture medium without affecting receptor function. As an application of this tractable method, the agonist-induced internalization of the human-derived 2-adrenergic receptor and epidermal growth factor receptor was successfully visualized.


Subject(s)
CHO Cells/cytology , Cell Membrane , Fluorescent Dyes/chemistry , Receptors, Cell Surface , Staining and Labeling , Animals , CHO Cells/metabolism , Cell Membrane/metabolism , Cell Membrane/pathology , Cell Membrane/ultrastructure , Cells, Cultured , Cricetinae , Cricetulus , ErbB Receptors/analysis , ErbB Receptors/metabolism , Humans , Mice , Receptors, Adrenergic, alpha-2/analysis , Receptors, Adrenergic, alpha-2/metabolism , Receptors, Cell Surface/analysis , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/metabolism , Receptors, Prostaglandin E/analysis , Receptors, Prostaglandin E/metabolism , Receptors, Prostaglandin E, EP3 Subtype , Time Factors
20.
Chemistry ; 14(5): 1392-401, 2008.
Article in English | MEDLINE | ID: mdl-18200641

ABSTRACT

Synthetic chemical probes designed to simultaneously targeting multiple sites of protein surfaces are of interest owing to their potential application as site specific modulators of protein-protein interactions. A new approach toward bivalent inhibitors of mammalian type I geranylgeranyltransferase (GGTase I) based on module assembly for simultaneous recognition of both interior and exterior protein surfaces is reported. The inhibitors synthesized in this study consist of two modules linked by an alkyl spacer; one is the tetrapeptide CVIL module for binding to the interior protein surface (active pocket) and the other is a 3,4,5-alkoxy substituted benzoyl motif that contains three aminoalkyl groups designed to bind to the negatively charged protein exterior surface near the active site. The compounds were screened by two distinct enzyme inhibition assays based on fluorescence spectroscopy and incorporation of a [(3)H]-labeled prenyl group onto a protein substrate. The bivalent inhibitors block GGTase I enzymatic activity with K(i) values in the submicromolar range and are approximately one order of magnitude and more than 150 times more effective than the tetrapeptide CVIL and the methyl benzoate derivatives, respectively. The bivalent compounds 6 and 8 were shown to be competitive inhibitors, suggesting that the CVIL module anchors the whole molecule to the GGTase I active site and delivers the other module to the targeting protein surface. Thus, our module-assembly approach resulted in simultaneous multiple-site recognition, and as a consequence, synergetic inhibition of GGTase I activity, thereby providing a new approach in designing protein-surface-directed inhibitors for targeting protein-protein interactions.


Subject(s)
Alkyl and Aryl Transferases/antagonists & inhibitors , Alkyl and Aryl Transferases/metabolism , Enzyme Inhibitors/pharmacology , Alcohols/chemistry , Alcohols/metabolism , Alkyl and Aryl Transferases/chemistry , Alkylation , Amines/chemistry , Amines/metabolism , Amino Acid Sequence , Benzoates/chemistry , Benzoates/metabolism , Binding Sites , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Isotope Labeling , Kinetics , Molecular Sequence Data , Oligopeptides/chemistry , Oligopeptides/metabolism , Prenylation , Protein Binding , Spectrometry, Fluorescence , Structure-Activity Relationship , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...